Bosutinib D8 is the octa-deuterated form of Bosutinib (SKI606; SKI-606; Bosulif), which is a dual Src/Abl kinase inhibitor approved for treating Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults.

纯度：≥98%